Unveiling CTL1 as the key choline transporter in oligodendrocytes: implication for myelin formation and maintenance

Active Project Grant Awarded Last action

Award ID
R21NS140995
Recipient
Awarding agency
Obligated
$667,250

Award facts

Completion date 95% complete
Place of performance
Newark, NJ 07102, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Oligodendrocytes rely heavily on choline to generate myelin membrane, as choline serves as a precursor to essential membrane phospholipids and signaling lipids. Additionally, choline is a source of methyl groups needed for many steps in metabolism and regulation of gene expression. Cells have a limited capacity to synthesize choline; thus, they must acquire IT from an extracellular source. Clinical importance of choline intake in myelination has been demonstrated. For instance, prenatal choline deficiency correlates with reduced white matter. Choline supplement has been shown promise in enhancing myelin repair in patience with multiple sclerosis. Despite the recognized significance of choline, we currently have limited understanding of how oligodendrocytes acquire this essential nutrient. The long-term goal of our study is to elucidate the mechanism of choline import and the implications in regulating oligodendrocyte myelination. The expression of choline transporter-like 1 (CTL1) in oligodendrocyte has been reported previously, peaking during active myelination and remaining sustained in adult brain. Since oligodendrocytes do not express CHT, the high-affinity transporter, these observations suggest the role of CTL1 as a choline transporter in oligodendrocytes. Supporting this, a recent human study links non-sense CTL1 mutations to early onset progressive white matter atrophy, highlighting the importance of CTL1 during myelination. The function of CTL1 in oligodendrocytes has not been elucidated. In this study, we aim to test the hypothesis that CTL1 is the main choline transporter in oligodendrocytes and plays a crucial role during oligodendrocyte generation and myelination. Two specific aims are proposed. Aim 1 do oligodendrocytes acquire choline through CTL1, and what are the implications on myelin lipid synthesis and oligodendrocyte differentiation? We will use maldi-TOF MS and lipidomic analysis to determine the impact of CTL1 loss on choline import and myelin lipid composition in oligodendrocytes. We will also use scrna-SEQ transcriptome analysis to define the impact of CTL1 loss on oligodendrocyte differentiation progression and gene expression aim 2 is CTL1 important for oligodendrocyte generation, myelination and myelin maintenance in vivo? Oligodendrocyte lineage-specific pdgfar-creer; CTL1FL/FL; eyfp and PLP-creer; CTL1FL/FL; eyfp mice will be used to temporally delete CTL1 in opcs and mature oligodendrocytes, respectively. Immunohistochemical, biochemical, and ultrastructural EM analyses will assess the impact of CTL1 loss on oligodendrocyte lineage development, myelination, and myelin maintenance. Overall, the study's findings have the potential to significantly advance our understanding of the importance of choline metabolism in myelin biology and provide new insights into developing targeted therapeutic strategies to enhance myelin repair in disorders associated with myelin dysfunction.

Transactions

Action Obligated Date
Amendment $196,250
Amendment $235,500
Original award $235,500

Quick answers

Who received award R21NS140995?

R21NS140995 was awarded to Rutgers, The State University by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on December 1, 2024.

How much is award R21NS140995 worth?

$667,250 has been obligated on R21NS140995.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login